Evidence map›Paper›PMID 40881191›Full record

ArticleSAGE open medical case reports2025

A case of appendiceal neuroendocrine tumor with metastatic spread in a young patient.

Fariha Hasan, Amir Davoodi, Amy Bordogna, Shrey Dalwadi, Yumna Timsaal, Avneet Singh, Alexander Garcia, Kim HooKim, Satyajeet Roy

Abstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fariha HasanDepartment of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.
Amir DavoodiCooper Medical School of Rowan University, Camden, NJ, USA.
Amy BordognaCooper Medical School of Rowan University, Camden, NJ, USA.
Shrey DalwadiCooper Medical School of Rowan University, Camden, NJ, USA.ORCID https://orcid.org/0009-0007-1035-6704
Yumna TimsaalDow University of Health Sciences, Karachi, Pakistan.
Avneet SinghDepartment of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.
Alexander GarciaDepartment of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.
Kim HooKimDepartment of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.
Satyajeet RoyDepartment of Internal Medicine, Cooper University Hospital, Camden, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Appendiceal neuroendocrine tumors are a rare subset of well-differentiated neuroendocrine tumors, comprising <1% of all malignancies. Appendiceal cancer is particularly rare, affecting approximately one to two individuals per one million annually in the United States. Appendiceal neuroendocrine tumors have an estimated incidence of 7/100,000 person-years in the United States. In this report, we present the case of a 19-year-old female who arrived to the emergency department with recurrent right lower quadrant pain, unresponsive to initial management for suspected acute appendicitis, and urinary tract infection. Advanced imaging revealed an appendiceal mucocele. The patient underwent appendectomy, and histopathology confirmed a well-differentiated appendiceal neuroendocrine tumor (grade 2) with lymphovascular invasion. A subsequent right hemicolectomy identified metastatic disease in 6 out of 27 lymph nodes. Unfortunately, the patient was lost to follow-up shortly after surgery. This case underscores the diagnostic complexities of appendiceal neuroendocrine tumors, which are often incidental findings during appendectomy and may present with nonspecific or atypical symptoms. It highlights the critical role of tumor size, grade, and histopathological evaluation in guiding management decisions, as well as the importance of a multidisciplinary approach to treatment. Moreover, it emphasizes the necessity of vigilant follow-up, particularly in young patients, to address the long-term implications of this rare malignancy and improve outcomes.

Indexed as

appendicitisappendixdiabetes/endocrinologyneuroendocrine tumoroncology

Identifiers

PMID40881191
PMCPMC12381439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.